89% reduction? And yet a study supported by Pfizer this month...

  1. 974 Posts.
    lightbulb Created with Sketch. 47
    89% reduction? And yet a study supported by Pfizer this month finds: “The time to sustained alleviation of all signs and symptoms of Covid-19 did not differ significantly between participants who received nirmatrelvir–ritonavir and those who received placebo. (Supported by Pfizer; EPIC-SR ClinicalTrials.gov number, NCT05011513.)”
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.